Risk Factors Associated With Ineligibility of Adjuvant Cisplatin-Based Chemotherapy After Nephroureterectomy

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s72197
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cerebral Infarction After Cisplatin-Based Chemotherapy.

Postgraduate Medical Journal
Medicine
1994English

Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer

Current Oncology
Oncology
2014English

Endovascular Treatment of Acute Abdominal Aortic Thrombosis After Cisplatin-Based Chemotherapy

Journal of Vascular Medicine & Surgery
2013English

Adjuvant Bidirectional Chemotherapy With Intraperitoneal Pemetrexed Combined With Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Gastroenterology Research and Practice
HepatologyGastroenterology
2012English

Relapse-Associated microRNA in Gastric Cancer Patients After S-1 Adjuvant Chemotherapy

Oncology Reports
MedicineCancer ResearchOncology
2013English

Risk Factors Associated With Delayed Haemorrhage After Pancreatic Resection

HPB
HepatologyGastroenterology
2012English

Identification of Risk Factors Associated With Postoperative Acute Kidney Injury After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Study

International Journal of Hyperthermia
MedicineCancer ResearchRadiologicalPhysiologyUltrasound Technology
2017English

Survival Analysis of Adjuvant Chemotherapy With S-1 Plus Cisplatin for Stage III Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2013English

The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients With Non-Small Cell Lung Cancer

Oncomedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy